1
|
Jallu V, Beranger T, Bianchi F, Casale C, Chenet C, Ferre N, Philippe S, Quesne J, Martageix C, Petermann R. Cab4b, the first human platelet antigen carried by glycoprotein IX discovered in a context of severe neonatal thrombocytopenia. J Thromb Haemost 2017; 15:1646-1654. [PMID: 28561420 DOI: 10.1111/jth.13744] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/15/2017] [Indexed: 11/28/2022]
Abstract
Essentials Life-threatening maternofetal thrombocytopenias mostly depend on αIIb β3 antigens. We performed serological, genomic and in vitro studies of two life-threatening thrombocytopenias. Identification of a c.368C>T variation leading to Pro123Leu substitution in GPIX. A rare GPIX variant reported in a genomic database define a new alloantigen. SUMMARY Background After three miscarriages, a 39-year-old woman gave birth, with a 1-year interval, to two severely thrombocytopenic neonates (4 ×109 L-1 and 33 ×109 L-1 ) with intracranial hemorrhages. Transfusion of platelet concentrates corrected the thrombocytopenia. The outcome was favorable for the first child, but the second one died 10 days after cesarean delivery (31 weeks of gestation + 6 days). Methods Serologic studies were performed with mAb-specific immobilization of platelet antigens and flow cytometry techniques. Human platelet alloantigen (HPA) genotyping was performed with the BioArray HPA BeadChip and PCR-sequence-specific primer techniques. Genomic DNA was studied by direct sequencing of PCR products. The mutant glycoprotein (GP) was expressed in transiently transfected HEK293 cells. Results In MAIPA assay, the maternal serum faintly reacted with GPIbIX from paternal and child 1 platelets, but not with maternal or panel platelets. No maternofetal incompatibility was found in the 22 known HPA systems, tested except for HPA-1b in child 2. A new alloantigen carried by GPIbIX was suspected. Genomic sequencing revealed a paternal GPIX variation (NM_000174.4:c.368C>T). The father and children were heterozygous and incompatible with the mother, who was NM_000174.4:c.368C homozygous. The maternal serum reacted with the GPIX NP_000165.1:p.Leu123 form coexpressed with GPIb in transfected HEK293 cells. The NM_000174.4:c.368T allele (rs202229101) has a minor allele frequency of 0.0002, and was not detected in 120 French subjects (families with fetal and neonatal alloimmune thrombocytopenia [FNAIT]), suggesting that it is rarely implicated in alloimmunization. Conclusion The NP_000165.1:p.Leu123 allele named Cab4b is the first platelet alloantigen described on GPIX. In the absence of other known maternofetal incompatibility, the child 1 case suggests that anti-Cab4b alloantibodies can induce severe thrombocytopenias.
Collapse
Affiliation(s)
- V Jallu
- Département d'Immunologie Plaquettaire, Institut National de la Transfusion Sanguine (INTS), Paris, France
| | - T Beranger
- Département d'Immunologie Plaquettaire, Institut National de la Transfusion Sanguine (INTS), Paris, France
| | - F Bianchi
- Département d'Immunologie Plaquettaire, Institut National de la Transfusion Sanguine (INTS), Paris, France
| | - C Casale
- Département d'Immunologie Plaquettaire, Institut National de la Transfusion Sanguine (INTS), Paris, France
| | - C Chenet
- Département d'Immunologie Plaquettaire, Institut National de la Transfusion Sanguine (INTS), Paris, France
| | - N Ferre
- Département d'Immunologie Plaquettaire, Institut National de la Transfusion Sanguine (INTS), Paris, France
| | - S Philippe
- Département d'Immunologie Plaquettaire, Institut National de la Transfusion Sanguine (INTS), Paris, France
| | - J Quesne
- Département d'Immunologie Plaquettaire, Institut National de la Transfusion Sanguine (INTS), Paris, France
| | - C Martageix
- Département d'Immunologie Plaquettaire, Institut National de la Transfusion Sanguine (INTS), Paris, France
| | - R Petermann
- Département d'Immunologie Plaquettaire, Institut National de la Transfusion Sanguine (INTS), Paris, France
| |
Collapse
|
2
|
Jallu V, Letoriellec E, Chenet C, Casale C, Quesne J, Beranger T, Bianchi F, Philippe S, Martageix C, Petermann R. Étude des polymorphismes géniques plaquettaires : discordance phénotype - génotype et impact de techniques standardisées sur l’interprétation du génotypage des alloantigènes plaquettaires humains (HPA). Transfus Clin Biol 2015. [DOI: 10.1016/j.tracli.2015.06.231] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
3
|
Petermann R, Martageix C, Jallu V, Garraud O. Prise en charge des allo-immunisations fœto-maternelles plaquettaires: le point de vue du biologiste médical. Transfus Clin Biol 2015. [DOI: 10.1016/j.tracli.2015.06.228] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
4
|
Brouk H, Bertrand G, Zermat B, Djabri Y, Martageix C, Kaplan C, Ouelaa H. Thrombopénies néonatales allo-immunes : difficultés diagnostiques. Transfus Clin Biol 2013. [DOI: 10.1016/j.tracli.2013.03.069] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
5
|
Bertrand G, Jallu V, Beranger T, Bianchi F, Casale C, Dufour V, Chenet C, Quesne J, Martageix C, Kaplan C. Nouvelle mutation sur le gène de l’intégrine α2 : implication pour le diagnostic d’allo-immunisation fœto-maternelle. Transfus Clin Biol 2013. [DOI: 10.1016/j.tracli.2013.03.080] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
6
|
Bertrand G, Bianchi F, Quesne J, Philippe S, Chenet C, Martageix C, Kaplan C. Thrombopénie néonatale sévère liée à l’allo-antigène rare HPA-12bw. Transfus Clin Biol 2013. [DOI: 10.1016/j.tracli.2013.03.079] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
7
|
Bertrand G, Jallu V, Beranger T, Bianchi F, Casale C, Dufour V, Chenet C, Quesne J, Martageix C, Kaplan C. HPA-5 typing discrepancy reveals an Ile503Leu substitution in platelet GPIa (α2 integrin). Vox Sang 2013; 105:73-6. [PMID: 23368983 DOI: 10.1111/vox.12019] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/15/2012] [Revised: 11/08/2012] [Accepted: 11/08/2012] [Indexed: 11/27/2022]
Abstract
BACKGROUND AND OBJECTIVES In fetal/neonatal thrombocytopenia, maternal alloimmunization is diagnosed by the identification of the maternal alloantibody and the offending paternal antigen inherited by the foetus/neonate. Today, for practical reasons, most laboratories perform platelet genotyping instead of phenotyping. Here, we report the case of a human platelet antigen (HPA)-5 genotype/phenotype discrepancy observed in a mother who delivered a mildly thrombocytopenic newborn. MATERIALS AND METHODS Platelet antibody detection and platelet phenotyping were performed using the MAIPA assay; platelet genotypes were determined using BeadChip technology (BioArray), PCR-SSP, PCR-RFLP and sequencing. RESULTS Serological investigations revealed the presence of maternal anti-GPIIbIIIa autoantibodies. No alloantibodies were detected. No feto-maternal platelet incompatibility was observed for HPA-1 to -21. The mother and newborn were genotyped as HPA-5aa using BeadChips, but as HPA-5a (weak b) with PCR-SSP and HPA-5ab with PCR-RFLP. Mother's platelets were phenotyped as HPA-5b(+). GPIa exon 13 sequencing confirmed the HPA-5ab genotype of the mother and newborn, and revealed an NM_002203.3:c.1594A>C mutation near the HPA-5 polymorphism (5' side), leading to an I503L amino acid change. CONCLUSION Feto-maternal alloimmunization was ruled out: the neonatal thrombocytopenia probably resulted from maternal anti-GPIIbIIIa autoantibodies. This case highlights that platelet typing should be performed using two different methods to avoid false diagnosis.
Collapse
Affiliation(s)
- G Bertrand
- Platelet Immunology Unit, INTS, Paris, France.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
8
|
Bertrand G, Martageix C, Jallu V, Vitry F, Kaplan C. Predictive value of sequential maternal anti-HPA-1a antibody concentrations for the severity of fetal alloimmune thrombocytopenia. J Thromb Haemost 2006; 4:628-37. [PMID: 16460445 DOI: 10.1111/j.1538-7836.2006.01809.x] [Citation(s) in RCA: 72] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
BACKGROUND Fetal/neonatal alloimmune thrombocytopenia results from maternal immunization against fetal platelet alloantigens (HPAs), and the major risk is intracranial hemorrhage. The severity of thrombocytopenia increases in subsequent pregnancies, and antenatal therapy has been developed. Until now, the fetal status can only be assessed by fetal blood sampling, which carries a risk of fetal loss or premature delivery. OBJECTIVES To develop non-invasive methods to gain information on the fetal condition. PATIENTS/METHODS Quantification of the maternal anti-HPA-1a alloantibody concentration was performed with a standardized monoclonal antibody-specific immobilization of platelet antigens (MAIPA) procedure for 43 mothers. A correlation between this concentration and the fetal/neonatal platelet counts was studied. RESULTS (i) Before antenatal therapy, there was a significant correlation between maternal anti-HPA-1a concentrations > or =250 AU mL(-1) and fetal thrombocytopenia (2-66 x 10(9) L(-1)) whatever the gestational age (Fisher's exact test P = 0.0021). (ii) During subsequent pregnancies, we observed a decrease of the maternal anti-HPA-1a concentration for 14/19 women. Just before delivery, all women had anti-HPA-1a concentrations <250 AU mL(-1). In four cases, there was a therapy failure and the severely thrombocytopenic babies required postnatal therapy. CONCLUSION The maternal anti-HPA-1a concentration could provide obstetricians with clinically useful information concerning the appropriateness and the timing of invasive monitoring procedures. However, though we observed a tendency toward a decrease in maternal antibody concentration after treatment, this finding does not allow us to draw any conclusions on the effectiveness of therapy.
Collapse
Affiliation(s)
- G Bertrand
- INTS, Platelet Immunology Unit, Paris, France
| | | | | | | | | |
Collapse
|
9
|
Halle L, Bigot A, Mulen-Imandy G, M'Bayo K, Jaeger G, Anani L, Martageix C, Bianchi F, Julien E, Kaplan C. HPA polymorphism in sub-Saharan African populations: Beninese, Cameroonians, Congolese, and Pygmies. ACTA ACUST UNITED AC 2005; 65:295-8. [PMID: 15730528 DOI: 10.1111/j.1399-0039.2005.00360.x] [Citation(s) in RCA: 43] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
The frequency of human platelet antigen-1 (HPA-1) to HPA-11w (excluding HPA-8w) and HPA-15 systems was studied in four sub-Saharan populations: Beninese, Congolese (Democratic Republic of Congo Kinshasa), Cameroonians, and Aka pygmies (Central African Republic). No report of HPA prevalence has previously been published concerning these populations which are characterized by the highest HPA-2b gene frequencies of any reported to date (Aka 0.393, Benin 0.292, Cameroon 0.237, and Congo 0.224) and at lesser degree HPA-5b (Aka 0.405, Congo 0.268, Cameroon 0.254, and Benin 0.182). This study is of great importance (i) particularly in the context of the diversity caused by the population migrations, we may observe today in our hospitals (ii) to confirm that the Pygmy population with distinctive frequencies (absence of the HPA-1b, HPA-2b, and HPA-5b highest frequencies) is an isolated population.
Collapse
Affiliation(s)
- L Halle
- Institut National de la Transfusion Sanguine, Paris, France
| | | | | | | | | | | | | | | | | | | |
Collapse
|
10
|
Halle L, Bach K H, Martageix C, Bianchi F, Lê T Kim T, Morel-Kopp MC, Soulier J, Tetaria C, Kaplan C. Eleven human platelet systems studied in the Vietnamese and Ma'ohis Polynesian populations. ACTA ACUST UNITED AC 2004; 63:34-40. [PMID: 14651521 DOI: 10.1111/j.1399-0039.2004.00149.x] [Citation(s) in RCA: 37] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
The frequencies of human platelet antigens (HPA) are variable among different ethnic groups. Platelet phenotyping and genotyping in different populations are important to the clinical implications of antiplatelet alloimmunization. No report on HPA prevalence has been published concerning the Vietnamese Kinh and Ma'ohis Polynesian populations. Recent anthropological and genetic marker studies suggest that these two groups have a common origin in East Asia, so we have conducted a combined study concerning the frequency of HPA-1 to HPA-11w systems (excluding HPA-8w) and Gov in these two populations. The results demonstrate a similar pattern of prevalence between Ma'ohis and most of the Asian populations. However, it should be noted that the frequency of HPA-2 is closer to northern Caucasian frequencies than to Asian frequencies. The population of Kinh shows an HPA distribution that is closer to the Chinese population than to the northeastern Thais except for HPA-3, closer to the Indonesian population. Given HPA-3 gene frequency distribution fetomaternal incompatibility could occur more frequently with the risk of alloantibody production.
Collapse
Affiliation(s)
- L Halle
- Institut National de la Transfusion Sanguine (INTS), Laboratoire d'Immunologie Plaquettaire, Paris, France
| | | | | | | | | | | | | | | | | |
Collapse
|
11
|
Mbayo K, Mbuyi-Muamba JM, Hallé L, Salmon D, Martageix C, Castellano F, Kaplan C, Lurhuma Z. HLA-DR gene frequencies in a Zaïrean population with particular reference to rheumatic diseases. Clin Rheumatol 1998; 17:105-9. [PMID: 9641505 DOI: 10.1007/bf01452254] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
Abstract
Epidemiological studies have shown that rheumatic diseases such as rheumatoid arthritis and systemic lupus erythematosus are uncommon in black Africans, and in this population the prevalence and the clinical features of these rheumatic diseases are variable. Environmental and genetic factors have been pointed out to explain this variability. In the present study, HLA-DR genes have been determined in a Zaïrean population in order to compare our results with those found elsewhere in other black populations of the same Bantu origin. Our results show that the frequency of HLA-DR1 is higher than in Nigerians, Zimbabweans and Xhosas, the decrease in Xhosas being statistically significant (p < 0.006). The HLA-DR3 frequency is higher in Zaïreans than in Nigerians but not significantly, while it is lower than in Xhosas (p < 0.003) and in Zimbabweans (not significant). The HLA-DR4 frequency is higher in Zaïreans than in Nigerians but it is lower than in Xhosas and Zimbabweans; the differences are not statistically significant. The HLA-DR8 frequency is lower in Zaïreans than in Nigerians while it is higher than in Xhosas (p < 0.002) and in Zimbabweans (not significant). These data suggest that genetic factors partly explain the clinical and epidemiological variability of rheumatic diseases in black Africans.
Collapse
Affiliation(s)
- K Mbayo
- Cliniques Universitaires de Kinshasa, Zaïre
| | | | | | | | | | | | | | | |
Collapse
|
12
|
Affiliation(s)
- L Halle
- Institut National de Transfusion Sanguine, Paris, France
| | | | | | | | | | | | | |
Collapse
|